Cargando…

Dosage of antipsychotics in China routine practice

INTRODUCTION: The antipsychotic dosage of Chinese schizophrenia patients has rarely been studied, although nonstandard dosage has impact on prognosis. OBJECTIVES: To describe the dosage of antipsychotics in China routine practice. METHODS: This was a retrospective cohort study using de-identified da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, T., Chi, R., Wu, T., Xu, Y., Dong, W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475991/ http://dx.doi.org/10.1192/j.eurpsy.2021.980

Ejemplares similares

Antipsychotics dosage and antiparkinsonian prescriptions
por: Acquaviva, Eric, et al.
Publicado: (2007)

Personalizing antipsychotic treatment: evidence and thoughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disorders
por: Wunderink, Lex
Publicado: (2019)

antipsychotics and metabolic syndrome
por: Jomli, R., et al.
Publicado: (2022)

Antipsychotic medication and the elderly
por: Jardak, D., et al.
Publicado: (2021)

Osteopenia and osteoporosis associated with hyperprolactinemic antipsychotics
por: Montejo, A. L., et al.
Publicado: (2023)

Off-label prescribing of antipsychotics: prescribing practices and clinical experiences of Finnish physicians
por: Rautio, N., et al.
Publicado: (2022)

Antipsychotics in elderly people: to prescribe or to ban?
por: Zbidi, M., et al.
Publicado: (2023)

Intellectual disability and antipsychotics
por: Iñiguez, I. Cuevas, et al.
Publicado: (2021)

Use of antipsychotics with tamoxifen
por: Ghabi, H., et al.
Publicado: (2021)

Defining dosage
por: Pellis, Tommaso
Publicado: (2015)

Antipsychotics and dementia
por: Gareri, P, et al.
Publicado: (2010)

Monitoring of antipsychotic plasma levels in the assessment of poor response and nonadherence to antipsychotics in delusional disorder
por: González-Rodríguez, A., et al.
Publicado: (2021)

PM393. Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
por: Joe, Soohyun, et al.
Publicado: (2016)

Antipsychotic prescription amongst the elderly: Descriptive and analytical study
por: Bouali, W., et al.
Publicado: (2023)

Thrombotic complications of treatment with antipsychotic drugs : risk factors
por: Abid, W., et al.
Publicado: (2023)

Characterization of “Responder” in patients with Treatment-Resistant Schizophrenia (TRS) treated with a new antipsychotic added to their current antipsychotic monotherapy
por: Anand, R., et al.
Publicado: (2023)

Pharmacogenetic testing in schizophrenia in real clinical practice: before or after antipsychotic -induced adverse drug reactions development?
por: Abdyrakhmanova, A., et al.
Publicado: (2022)

Hormonal alterations due to antipsychotic-related hyperprolactinemia
por: Montejo, A.L., et al.
Publicado: (2022)

Drug-induced liver injury in association with antipsychotics
por: Zeiss, R., et al.
Publicado: (2022)

Delirium, Antipsychotics and Death in the time of COVID-19
por: Softic, R., et al.
Publicado: (2023)

Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
por: Pae, Chi-Un, et al.
Publicado: (2021)

Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
por: Pae, Chi-Un, et al.
Publicado: (2020)

Can atypical antipsychotic drugs cause hepatotoxicity?
por: André, R., et al.
Publicado: (2021)

Antipsychotics in off-label use: prescription practices, benefits and risks Results from APSY Oulu study
por: Jääskeläinen, E.
Publicado: (2023)

Antipsychotics for elderly with psychosis: Deprescribe or continue?
por: Mohr, P.
Publicado: (2021)

How to manage antipsychotic-induced akathisia
por: Moura, N., et al.
Publicado: (2021)

Antipsychotics use in dementia: How safe are they?
por: Lopes, C.
Publicado: (2021)

13.2 CANNABIDIOL AS AN ANTIPSYCHOTIC DRUG
por: Guimaraes, Francisco, et al.
Publicado: (2018)

Antipsychotic and Psychotropic Prescribing in Assisted Living
por: Zimmerman, Sheryl, et al.
Publicado: (2020)

Management of antipsychotic-related sexual dysfunction
por: Rodrigues, C.
Publicado: (2022)

EXPERIENCE OF PHARMACOGENETIC TESTING IN THE TREATMENT OF ANTIPSYCHOTICS
por: Kaydan, M., et al.
Publicado: (2023)

Correlates of late-onset antipsychotic treatment resistance
por: Fonseca De Freitas, D., et al.
Publicado: (2022)

Off-label use of atypical antipsychotics- Where are we?
por: Vaz, R. P., et al.
Publicado: (2023)

Outcome Measurement and Evaluation as a Routine practice in alcohol and other drug services in Belgium (OMER-BE)
por: Migchels, C., et al.
Publicado: (2023)

Antipsychotic-induced priapism: case report and review of the literature.
por: Machado, D. R., et al.
Publicado: (2023)

Reduction of Radiation Dosage in Visualization of Paranasal Sinuses in Daily Routine
por: Güldner, Christian, et al.
Publicado: (2017)

Effective therapeutic dosage of antipsychotic medications in patients with psychotic symptoms: Is there a racial difference?
por: Bakare, Muideen O
Publicado: (2008)

Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder
por: Pilhatsch, Maximilian, et al.
Publicado: (2018)

Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
por: Ringen, Petter Andreas, et al.
Publicado: (2019)

Prescribing of Antipsychotic Medication in a Medicaid Population: Use of Polytherapy and Off-Label Dosages
por: Kogut, Stephen J., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_86h5v91mr2bv410ejm10532819